|
| iNPH | PD |
|
Prevalence | 2 cases/1000 in individuals > 70 years old [13] | 10 cases/1,000 in individuals 70–79 years old [14] |
|
Age at onset | Adults over the age of 60 | Incidence peak between 70 and 79 years |
|
Urinary disturbance | Common, nonspecific | Common, nonspecific |
|
Cognitive dysfunction | Frontal, executive dysfunction | Frontal, executive dysfunction; global cognitive impairment usually denotes disease progression |
|
Bradykinesia | 62% of patients display bradykinesia affecting their lower limbs symmetrically; upper limbs are typically spared | Cardinal feature of the disease; upper limbs are usually affected early on in an asymmetric fashion |
|
Rest tremor | Absent | Cardinal feature of the disease; observed in about 60% of patients |
|
Rigidity | Rare | Cardinal feature of the disease; observed in about 60% of patients |
|
Hallucinations | Absent | Usually manifesting with visual misperceptions and passage illusions with retained insight; florid hallucinations typically arise in advanced stages |
|
Cortical deficits (aphasia, apraxia, agnosia) | Absent | Rare |
|
Response to L-dopa | Absent, mild, or inconsistent | Excellent, sustained, supportive diagnostic criteria |
|
Response to shunt placement | >60% of patients | Absent |
|
MRI/CT | Ventriculomegaly | Noncontributory |
|
Time course of gait failure | Early feature | If present early, regarded as a “red flag” for the diagnosis of disease |
|
Gait velocity | Decreased | Decreased |
|
Step length | Decreased | Decreased |
|
Arm swing | Normal | Reduced or abolished |
|
Freezing of gait | Early feature | Most commonly observed in the advanced stages |
|
Responsiveness to cues | Absent or poor | Significant |
|
Step height | Reduced | Reduced |
|
Base | Wide | Narrow |
|